Categories: Health Care

Babies fed with INFAT® OPO sleep more at night – thanks to newly discovered 7th health benefit

Bengaluru, March 20, 2016: Infant formula companies who include Advanced Lipid’s INFAT® OPO in their products can now use a compelling and scientifically-proven ‘Super Comfort’ marketing proposition in association with their brands.

A series of clinical trials have demonstrated that INFAT® OPO offers four separate benefits associated with baby’s comfort. This includes new preliminary evidence that infants fed with formula containing INFAT® OPO sleep for longer over the course of 24 hours and also during the night.

In total, this means INFAT® OPO has now been demonstrated to offer seven benefits, all of which are scientifically supported.

Four of these beneficial health effects are in the area of comfort, as follows:

Night sleep (the new 7th benefit) – A double-blind randomized controlled study involving 159 healthy term infants showed that infants fed formula containing INFAT® tend to enjoy more sleep at 6 weeks and 12 weeks than babies fed with control formula

Less crying – INFAT® is clinically proven to reduce crying time by up to 75% in healthy term babies – mainly in the late afternoon and evening – during the first weeks of their lives

Gut comfort – babies fed with formula containing INFAT® enjoy similar levels of beneficial gut bacteria to those found in breast-fed babies, promoting a healthy digestion and immune system

Softer stools – INFAT® promotes softer stools and in doing so reduces incidences of hard stools by as much as 50% compared with control formula

In addition to significantly greater levels of comfort, INFAT® optimizes the uptake of calcium, fat and energy. It has also been shown that bone strength in babies fed with INFAT® is similar to that found in breast-fed babies. Finally, bringing the list of benefits to seven, INFAT® has been shown to have a protective effect against gut inflammation, thereby enhancing gut health.

INFAT® OPO as an infant formula ingredient is unique in that it is a single ingredient that has been demonstrated to offer four comfort related benefits – something no other ingredient on the market can match. This means formula manufacturers can now market their products with a ‘Super Comfort’ positioning that will appeal to parents all over the world.

Avner Avissara, CEO of Advanced Lipids, commented: “Baby’s comfort is a high priority for parents of young babies, since it impacts on the whole family. An uncomfortable infant cries more and sleeps less – leading to stress and tiredness for parents. This means formula that promises increased comfort is an appealing proposition that resonates with mothers when they shop the baby aisle in-store. With INFAT® OPO, formula manufacturers can now use the Super-Comfort positioning to stand out on-shelf and gain a significant edge on their competitors.”

With INFAT® OPO it is now possible to create a formula with a fat composition that is closer than ever to breast milk in terms of structure and benefits. Breast milk is always best for baby, but when it isn’t possible to breast-feed, formula made with INFAT® OPO offers the next best solution, so parents can be confident they are giving their child a great start in life through optimum nutrition.

INFAT® OPO is an SN2 palmitate fat ingredient that when added as the fat component to infant formula mimics the composition and properties of human milk fat.

Produced in Europe using a patented enzymatic process, INFAT® delivers structured triglycerides with a high level of palmitic acid in the mid position of the triglyceride for optimal infant development and wellbeing. It is manufactured in state-of-the-art production facilities operated by AAK, which meet all of the most stringent European quality standards.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

CARE Hospitals, Nampally, Hosts the 12th National Infection Prevention and Control (IPC) Certificate Program

Hyderabad, November 22, 2024: CARE Hospitals, Nampally, successfully hosted the 12th National Infection Prevention and Control (IPC)…

2 days ago

61-Year-Old African Doctor morbidly Obese successfully treated for End-Stage Renal Disease via Robot-Assisted Kidney Transplant at Fortis Hospital Cunningham Road

Bengaluru, November 22, 2024: Fortis Hospital, Cunningham Road successfully performed a life-enhancing robot-assisted kidney transplant on 61-year-old…

2 days ago

Lung Cancer Awareness Month

By Dr. C N Patil, HOD and Lead Consultant - Medical Oncology & Haemato-Oncology, Aster…

3 days ago

Unmasking COPD: The Silent Respiratory Threat of Smoking

By  Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital …

3 days ago

Khazi India Foundation to Host Expert Cardiac Consultations in Adoni

Kurnool, November 20, 2024: Adoni, Andhra Pradesh, – The Khazi India Foundation is pleased to…

4 days ago

Aakash Healthcare Celebrates Children’s Day with Kids from Choti Si Khushi

New Delhi, November 20, 2024: Aakash Healthcare marked this year’s Children’s Day with a joyful…

4 days ago